Related Experiment Video
Updated: Jun 14, 2025

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
Metabolic regulation of the mitochondrial immune checkpoint
David C Montrose1,2, Suchandrima Saha1, Lorenzo Galluzzi3,4,5
1Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Abstract:
Disrupting mitochondrial function in malignant cells is a promising strategy to enhance anticancer immunity. We have recently demonstrated that depriving colorectal cancer cells of serine results in mitochondrial dysfunction coupled with the cytosolic accumulation of mitochondrial DNA and consequent activation of CGAS- and STING-dependent tumor-targeting immune responses.
Insights
Depriving colorectal cancer cells of serine disrupts mitochondrial function, leading to immune system activation against tumors. This strategy enhances anticancer immunity by leveraging mitochondrial DNA release and innate immune sensors.
Area of Science:
- Immunology
- Cancer Biology
- Metabolic Therapy
Background:
- Malignant cells possess unique metabolic vulnerabilities.
- Mitochondrial dysfunction can be therapeutically induced to elicit anti-tumor responses.
- Cytosolic DNA sensing pathways, including cGAS-STING, are crucial for innate immunity and cancer surveillance.
Discussion:
- Serine deprivation impairs mitochondrial function in colorectal cancer cells.
- This metabolic disruption causes mitochondrial DNA to leak into the cytosol.
- Leaked mitochondrial DNA triggers the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, activating anti-tumor immunity.
Key Insights:
- Targeting cellular metabolism, specifically serine synthesis, offers a novel approach to cancer therapy.
- Inducing mitochondrial dysfunction can reprogram the tumor microenvironment to be immunologically hostile to cancer cells.
- The cGAS-STING pathway is a critical mediator of the anti-tumor immune response initiated by metabolic stress.
Outlook:
- Further investigation into serine metabolism and mitochondrial integrity in cancer is warranted.
- This approach holds potential for combination therapies to enhance existing cancer treatments.
- Exploring serine deprivation in other cancer types could broaden therapeutic applications.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Inner Mitochondrial Membrane
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

